Recursion Pharmaceuticals, Inc.
NASDAQ: RXRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Najat Khan
- Employees
- 800
- Headquarters
- Salt Lake City, United States
- IPO year
- 2021
- Market cap
- $1.4B
- Website
- https://www.recursion.com
Loading RXRX…
Loading profile data…Frequently asked questions about RXRX
What does Recursion Pharmaceuticals, Inc. (RXRX) do?
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. The...
Where does RXRX trade?
Recursion Pharmaceuticals, Inc. (RXRX) trades on the NASDAQ Global Select.
What sector is RXRX in?
Recursion Pharmaceuticals, Inc. (RXRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Recursion Pharmaceuticals, Inc.?
Najat Khan is the chief executive officer of Recursion Pharmaceuticals, Inc. (RXRX).
Where is Recursion Pharmaceuticals, Inc. headquartered?
Recursion Pharmaceuticals, Inc. is headquartered in United States.
Does RXRX pay a dividend?
Recursion Pharmaceuticals, Inc. (RXRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RXRX go public?
Recursion Pharmaceuticals, Inc. (RXRX) completed its initial public offering in 2021.